Sanofi & Oxford University form Indian oncology deal

- Last updated on GMT

Sanofi-aventis and Oxford University have partnered with Indox to further clinical and translational oncology research in India.

Indox includes a network of eight cancer research centres that will receive good clinical practice (GCP) training and support from Oxford University. Sanofi will financially support the work Oxford University performs for Indox.

"This relationship not only helps to train the next generation of cancer researchers in India, but also allows sanofi-aventis to efficiently develop drugs in the premier cancer centres in India​”, said Debasish Roychowdhury, senior vice president, head of oncology, sanofi.

Related topics: Clinical Development, Sanofi

Related news